Lev Pharmaceuticals names three companies to dispense Cinryze when it is approved.
Because a Food & Drug Administration advisory committee has given approval to Lev Pharmaceuticals’ Cinryze [C1 inhibitor, (human)}, the New York company is getting ready for its final approval and distribution.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.